Sophie Tourdot

Sophie Tourdot

Pfizer Inc. - New York / United States
Medical and Health Sciences / Pharmacy & Pharmaceutical Sciences
AD Scientific Index ID: 4382550
-
person_outline Sophie Tourdot's MOST POPULAR ARTICLES
1-) H‐2 class I knockout, HLA‐A2. 1‐transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategiesH Firat, F Garcia‐Pons, S Tourdot, S Pascolo, A Scardino, Z Garcia, ...European journal of immunology 29 (10), 3112-3121, 19992341999
2-) A general strategy to enhance immunogenicity of low‐affinity HLA‐A2. 1‐associated peptides: implication in the identification of cryptic tumor epitopesS Tourdot, A Scardino, E Saloustrou, DA Gross, S Pascolo, P Cordopatis, ...European journal of immunology 30 (12), 3411-3421, 20002142000
3-) HER-2/neu and hTERT cryptic epitopes as novel targets for broad spectrum tumor immunotherapyA Scardino, DA Gross, P Alves, JL Schultze, S Graff-Dubois, O Faure, ...The Journal of Immunology 168 (11), 5900-5906, 20021722002
4-) Protection against lethal viral infection by vaccination with nonimmunodominant peptides.M Oukka, JC Manuguerra, N Livaditis, S Tourdot, N Riche, I Vergnon, ...Journal of immunology (Baltimore, Md.: 1950) 157 (7), 3039-3045, 19961151996
5-) Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance inductionN Saint‐Lu, S Tourdot, A Razafindratsita, L Mascarell, N Berjont, ...Allergy 64 (7), 1003-1013, 20091142009